FTC Approves Final Order Settling Horizon Therapeutics Acquisition Challenge
Date
The Federal Trade Commission today finalized a consent order that resolves potential competitive harm stemming from Amgen Inc.’s acquisition of Horizon Therapeutics plc. As part of a nationwide...